# Vero Biotech Inc.: Form D filings

Vero Biotech Inc., a pharmaceuticals company in Atlanta, GA, filed 7 Form D notices with the SEC between 2009 and 2021. The latest, on December 22, 2021, reports $27.3 million sold of a $99.5 million offering to 5 investors.

Find out what Vero Biotech Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Vero%20Biotech%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Vero%20Biotech%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvero-biotech-inc-1359620)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Vero%20Biotech%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Vero%20Biotech%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvero-biotech-inc-1359620)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Georgia](https://specstream.ai/data/form-d/state/georgia): 1,337 rows, by operating companies, filed since November 1, 2024, $66.85, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/georgia
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 387 TECHNOLOGY CIR. NW, SUITE 125, Atlanta, GA, 30313
- Phone: (678) 862-7729
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1359620

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 22, 2021 | New notice | $99,530,958 | $27,265,773 | $72,265,185 | 5 | Dec 8, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1359620/000135962021000005/0001359620-21-000005-index.htm) |
| Sep 29, 2017 | New notice | $35,100,000 | $29,941,000 | $5,159,000 | 31 | Sep 1, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1359620/000135962017000002/0001359620-17-000002-index.htm) |
| Oct 18, 2013 | Amendment | $17,000,000 | $14,738,606 | $2,261,394 | 41 | Sep 20, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1359620/000135962013000004/0001359620-13-000004-index.htm) |
| Oct 3, 2013 | New notice | $14,570,606 | $14,570,606 | $0 | 39 | Sep 20, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1359620/000135962013000003/0001359620-13-000003-index.htm) |
| Dec 29, 2011 | New notice | $10,500,000 | $7,990,819 | $2,509,181 | 21 | Feb 17, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1359620/000135962011000002/0001359620-11-000002-index.htm) |
| Sep 14, 2009 | New notice | $3,500,000 | $2,136,030 | $1,363,970 | 18 | Sep 2, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1359620/000135962009000004/0001359620-09-000004-index.htm) |
| Sep 14, 2009 | New notice | $3,000,000 | $2,136,030 | $863,970 | 18 | Sep 2, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1359620/000135962009000003/0001359620-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Todd Brady | Director |  |
| Daniel Salazar | Director |  |
| Thiago V. Tavares | Director |  |
| Shasha V. Zou | Executive Officer |  |
| Eric V. Bednarski | Director |  |
| Brent V. Furse | Executive Officer, Director |  |
| Roberto V. Cohen | Executive Officer |  |

## Other pharmaceuticals companies in Georgia that filed recently

- [Laurentide Therapeutics Inc.](https://specstream.ai/data/form-d/company/laurentide-therapeutics-inc-2157396) $99,999 · Sep 28, 2026
- [LifeCyte Innovations, Inc.](https://specstream.ai/data/form-d/company/lifecyte-innovations-inc-2150601) $1 million · Aug 20, 2026

[Every Form D from the week of Dec 20, 2021](https://specstream.ai/data/form-d/week/2021-12-20) · [All recent filings in Georgia](https://specstream.ai/data/form-d/state/georgia) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Vero Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).